Reyes-Vallejo, N.; Valdes, M.; Reyes-RamÃrez, A.; Alvarado-Salazar, J.A.; Cruz, A.; Andrade-Jorge, E.; Mendieta-Wejebe, J.E.
Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications. Molecules 2025, 30, 3427.
https://doi.org/10.3390/molecules30163427
AMA Style
Reyes-Vallejo N, Valdes M, Reyes-RamÃrez A, Alvarado-Salazar JA, Cruz A, Andrade-Jorge E, Mendieta-Wejebe JE.
Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications. Molecules. 2025; 30(16):3427.
https://doi.org/10.3390/molecules30163427
Chicago/Turabian Style
Reyes-Vallejo, Natalia, Miguel Valdes, Adelfo Reyes-RamÃrez, Juan Andres Alvarado-Salazar, Alejandro Cruz, Erik Andrade-Jorge, and Jessica Elena Mendieta-Wejebe.
2025. "Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications" Molecules 30, no. 16: 3427.
https://doi.org/10.3390/molecules30163427
APA Style
Reyes-Vallejo, N., Valdes, M., Reyes-RamÃrez, A., Alvarado-Salazar, J. A., Cruz, A., Andrade-Jorge, E., & Mendieta-Wejebe, J. E.
(2025). Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications. Molecules, 30(16), 3427.
https://doi.org/10.3390/molecules30163427
